Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 3.30
Ask: 3.50
Change: 0.05 (1.49%)
Spread: 0.20 (6.061%)
Open: 3.35
High: 3.40
Low: 3.35
Prev. Close: 3.35
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MIDEAST STOCKS-Qatar outperforms in soft Gulf markets

Tue, 20th Mar 2018 14:31

* Qatar index at three-week high

* In Saudi, Al Rajhi Bank up 1.7 percent

* Kingdom Holding barely moves on Alwaleed comments

* Abu Dhabi index down, Dubai flat

* Emaar Properties up, Aldar down before partnership news

By Tom Arnold

DUBAI, March 20 (Reuters) - Qatar's stocks outperformed ingenerally weak Gulf markets on Tuesday as investors awaited aU.S. interest rate hike expected at the Federal Reserve policymeeting on Wednesday.

In Qatar, the index rose 1.0 percent to its highestlevel in just over three weeks. The Al Rayan Qatarexchange-traded fund will list on Wednesday, giving the market asecond locally listed ETF as part of efforts to improveliquidity and attract more investment.

Drilling rig provider Gulf International Serviceswas the top gainer, rising 9.8 percent in unusually heavy trade,while Qatari Investors Group climbed 4.1 percent.

Qatar National Bank, which had attracted buying inrecent days due to its move to boost foreign ownership limit,was sold off on Tuesday. It closed 0.4 percent lower.

The region's biggest market, Saudi Arabia, was up0.2 percent with financial stocks among the largest gainersahead of an expected decision by FTSE at the end of this monthto include Riyadh in its secondary emerging market index.

Al Rajhi Bank, the kingdom's second largest bankby assets, rose 1.7 percent, while Saudi British Bankwas up 2.3 percent.

"It's been a waiting game until March 28 when a decision byFTSE is expected," said Khaled Feda, senior research manager atAlistithmar Capital. "The banking sector is outperforming theSaudi market year-to-date. We expect nine out of the 12 listedbanks to be included in the index."

Kingdom Holding barely moved, edging up just 0.2percent after chairman Prince Alwaleed bin Talal, in aninterview with Bloomberg after his release from detention in thecountry's crackdown on corruption, said he had signed a secretagreement with authorities and declined to give any details.

He also said Kingdom was looking at splitting its $13billion of assets by spinning off some domestic property andother holdings.

The Abu Dhabi index was down 0.4 percent with FirstAbu Dhabi Bank (FAB) unchanged. On Monday FAB, theUnited Arab Emirates' biggest lender, denied a claim by Qatariauthorities that it had tried to manipulate the Qatari riyal.

Aldar Properties was down 2.7 percent. In anannouncement after the market close, Dubai's ruler said Aldarand Emaar Properties, the top Dubai-based developer,were partnering to launch local and international projects worth30 billion dirhams ($8.2 billion).

The Dubai index was flat as banks dropped buthealthcare and industrial firms edged higher. Emaar Propertiesrose 1.0 percent.

SAUDI ARABIA

* The index rose 0.2 percent to 7,725 points.

DUBAI

* The index lost 0.02 percent to 3,183 points.

ABU DHABI

* The index fell 0.4 percent to 4,525 points.

QATAR

* The index rose 1.0 percent to 8,978 points.

EGYPT

* The index dipped 0.3 percent to 17,114 points.

KUWAIT

* The index edged down 0.6 to 6,706 points.

BAHRAIN

* The index went down 0.5 percent to 1,341 points.

OMAN

* The index edged down 1.05 percent to 4,782 points.(Editing by Andrew Torchia and David Evans)

More News
30 Apr 2024 19:54

EARNINGS AND TRADING: Software Circle & Beximco report higher revenue

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
15 Apr 2024 13:29

Fusion Antibodies inks commercial contract for OptiPhage library

(Alliance News) - Fusion Antibodies PLC on Monday said that it has signed a commercial contract to develop an OptiPhage library for a non-human antibody species.

Read more
27 Feb 2024 14:18

TRADING UPDATES: Sondrel wins USD23 million contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
27 Feb 2024 13:15

Fusion Antibodies gets first order under new services agreement

(Sharecast News) - Fusion Antibodies announced the receipt of its first purchase order under a master services agreement on Tuesday, which it agreed with a prominent diagnostics company on 14 February.

Read more
14 Feb 2024 12:52

Fusion Antibodies raises £1.38m as it seeks new customers

(Sharecast News) - Pre-clinical antibody specialist Fusion Antibodies announced a conditional fundraising of £1.38m before expenses on Wednesday, to help it target mo re industry conferences and customers and generate further supporting data.

Read more
14 Feb 2024 11:27

IN BRIEF: Fusion Antibodies raises GBP1.4 million via placing

Fusion Antibodies PLC - Belfast-based contract researcher, which provides discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Conditionally raises GBP1.4 million before expenses via placing of 34.4 million shares at 4 pence each. The issue price represents a discount of 5.9% to Fusion's closing mid-market share price on Tuesday. Further, it intends to issue 1.5 million new shares to certain directors in lieu of or in satisfaction of salary and fees due to them and which shall be issued immediately following publication of its announcement. Also intends to grant a total of up to 3.8 million new share options to staff and senior management.

Read more
6 Feb 2024 11:48

Fusion Antibodies strikes follow-on research and development project

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has won a follow-on project under a collaborative research and development agreement with an unnamed "US-based biotechnology company".

Read more
6 Feb 2024 10:05

AIM WINNERS & LOSERS: Beeks Financial Cloud is ahead of expectations

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
1 Feb 2024 16:27

Fusion Antibodies confirms £0.28m tax credit

(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies announced the successful receipt of a research and development tax credit from HMRC on Thursday.

Read more
1 Feb 2024 12:00

Fusion Antibodies gets tax credit from UK HMRC for OptiMAL platform

(Alliance News) - Fusion Antibodies PLC on Thursday announced the receipt of a research & development tax credit from UK HM Revenue & Customs for work performed on the development of its OptiMAL platform and other projects in bioinformatics.

Read more
4 Dec 2023 16:56

LONDON MARKET CLOSE: FTSE 100 slips as miners hold down index

(Alliance News) - Stock prices in London closed lower on Monday, with miners and oil firms holding down the FTSE 100 index.

Read more
4 Dec 2023 12:01

Fusion Antibodies revenue falls, losses widen in first half

(Sharecast News) - Contract research organisation Fusion Antibodies reported first-half revenue of £0.54m on Monday, down from £1.9m a year earlier.

Read more
4 Dec 2023 10:23

AIM WINNERS & LOSERS: Cornerstone FS to beat 2023 expectations

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
4 Dec 2023 10:22

Fusion Antibodies shares fall with revenue despite "positive" outlook

(Alliance News) - Fusion Antibodies PLC on Monday reported a widened loss and reduced revenue for its latest half year, but said its growth prospects are "increasingly positive".

Read more
28 Nov 2023 12:09

Fusion Antibodies shares up on deal with US National Cancer Institute

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has signed a collaboration agreement with the US National Cancer Institute to use its OptiMAL product to discover novel antibodies to treat certain targets.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.